ICAM1 and systemic inflammatory response syndrome: ICAM-1 activates leukocytes and endothelial cells (ECs), which in turn prompt the release of various inflammatory mediators, resulting in systemic inflammatory response syndrome (SIRS), acute respiratory distress syndrome (ARDS) and multi-organ dysfunction syndrome (MODS)[48]–[51].